Antigens in chronic lymphocytic leukemia--implications for cell origin and leukemogenesis.
about
Modeling tumor-host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapyThe MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemia.Silenced B-cell receptor response to autoantigen in a poor-prognostic subset of chronic lymphocytic leukemia.CLL cells respond to B-Cell receptor stimulation with a microRNA/mRNA signature associated with MYC activation and cell cycle progressionToll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patientsFrequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans.Partial versus productive immunoglobulin heavy locus rearrangements in chronic lymphocytic leukemia: implications for B-cell receptor stereotypyT cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production.Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cellsAccelerated progression of chronic lymphocytic leukemia in Eμ-TCL1 mice expressing catalytically inactive RAG1.DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemiaMultiple productive immunoglobulin heavy chain gene rearrangements in chronic lymphocytic leukemia are mostly derived from independent clonesChronic lymphocytic leukemia: an update on biology and treatment.RNA-based markers as prognostic factors in chronic lymphocytic leukemia.Geography, ethnicity and "roots" in chronic lymphocytic leukemia.Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?An update on current and prospective immunotherapies for chronic lymphocytic leukemia.Natural IgM antibodies in the immune defence against neoehrlichiosis.Cytoplasmic myosin-exposed apoptotic cells appear with caspase-3 activation and enhance CLL cell viability.Molecular characterization of neoplastic and normal "sister" lymphoblastoid B-cell lines from chronic lymphocytic leukemia.Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection.Biological and clinical significance of stereotyped B-cell receptors in chronic lymphocytic leukemia.Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2.B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalities.Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.NF-κB in Hematological Malignancies.The miR-17∼92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes.
P2860
Q34020276-BD4A3C4F-7B2A-4772-8C4B-18877F3B8951Q34097631-F610581C-452D-4CDE-80B0-F91D0C59ABF1Q34463658-D12361D3-EC8A-47BE-A1C3-ECE97ECD049FQ34656369-C8ECBF20-EE62-4603-B7E1-A54DA6011A90Q35528659-DF3BEA9B-D06F-4D0E-B716-A7AB4328AC5EQ35741703-BA672E2B-BDFD-4F96-9EF1-0487F73E23BEQ35747546-382AEA85-D2CD-469D-B734-7B7F02B03EA5Q36654128-D20488E0-0492-4288-991E-A857C8B3DA6BQ36777093-030B8AF5-7100-437F-9E28-9338C05326E0Q36979261-9CFCC15C-04A1-4E5C-A7A5-82383CDBB92FQ37130889-2B3DA5FE-5FC8-4DE1-8D05-85286CAF51F6Q37552043-4699A618-6882-4595-8817-F074F690BB49Q37902948-67FB76BE-3566-42C0-83DD-6F09AC934210Q37978344-1B94C1DF-C5C4-48FD-A815-812D56534023Q38057402-D62F7DFB-204C-4240-B2B6-EEF80F8FA5F1Q38088354-8837792C-ABB4-449A-8171-7D9F81FA6D62Q38445357-E3927B2E-49A3-4623-BCD0-A21A0AACF671Q38691383-F9AEBE14-C526-4F2C-95C6-2C83C7521B10Q38848453-9697C138-4660-4787-B28D-05B04A944F99Q39214500-C46D4371-B351-479C-9034-1DC9F7F55BF2Q39327432-8799B285-5351-41BF-84F5-31762643F7A5Q42337469-534E6C8D-4EEB-4F27-9FF7-6E0ADE67AF04Q44895447-76CF624D-4917-4B42-BAF2-066814D7A1A3Q45940002-F0A3467E-614D-409B-A427-76E58E1D6953Q52643368-9FE190EF-CEC8-4753-A792-78ECD887D81BQ54147337-230B6618-3030-4F93-A496-2D23FCDE2EA9Q54323506-A95E5E61-C63B-4615-B16C-00F345946F20
P2860
Antigens in chronic lymphocytic leukemia--implications for cell origin and leukemogenesis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antigens in chronic lymphocyti ...... ell origin and leukemogenesis.
@en
Antigens in chronic lymphocyti ...... ell origin and leukemogenesis.
@nl
type
label
Antigens in chronic lymphocyti ...... ell origin and leukemogenesis.
@en
Antigens in chronic lymphocyti ...... ell origin and leukemogenesis.
@nl
prefLabel
Antigens in chronic lymphocyti ...... ell origin and leukemogenesis.
@en
Antigens in chronic lymphocyti ...... ell origin and leukemogenesis.
@nl
P2093
P1476
Antigens in chronic lymphocyti ...... ell origin and leukemogenesis.
@en
P2093
Anders Rosén
Chamilly Evaldsson
Fiona Murray
Richard Rosenquist
P304
P356
10.1016/J.SEMCANCER.2010.09.004
P577
2010-09-21T00:00:00Z